VIA
IMGN

Vantage Investment Advisors’s Immunogen Inc IMGN Stock Holding History

Vantage Investment Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-3,000
Closed -$18K – 886
2014
Q4 		$18K Hold
3,000
– – 0.01% 407
2014
Q3 		$32K Hold
3,000
– – 0.02% 285
2014
Q2 		$36K Hold
3,000
– – 0.02% 277
2014
Q1 		$45K Buy
+3,000
New +$47.3K 0.03% 227

Other funds holding IMGN

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Vantage Investment Advisors's IMGN Position: Q1 2015 in Review

Vantage Investment Advisors sold out of Immunogen Inc (IMGN) in Q1 2015, closing a stake of 3,000 shares — an estimated $18K sold.

Vantage Investment Advisors first reported a position in IMGN in Q1 2014 and held it in 4 quarters. The position peaked at $45K in Q1 2014. 141 funds tracked by Wall St. Rank hold IMGN as of Q1 2015.

  • Vantage Investment Advisors reported no remaining Immunogen Inc position as of Q1 2015 after selling out during the quarter.
  • Vantage Investment Advisors sold 3,000 Immunogen Inc shares in Q1 2015, an estimated $18K.
  • Vantage Investment Advisors first reported a position in Immunogen Inc in Q1 2014 and held it in 4 quarters.
  • Vantage Investment Advisors's Immunogen Inc position peaked at $45K in Q1 2014.
  • 141 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2015.

Based on Vantage Investment Advisors's 13F filing for Q1 2015, filed 4 May 2015.